Skip to main content
TruTrace Technologies Inc. logo

TruTrace Technologies Inc. — Investor Relations & Filings

Ticker · TTT ISIN · CA8984471075 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 147 across all filing types
Latest filing 2022-12-23 Regulatory Filings
Country CA Canada
Listing CSE TTT

About TruTrace Technologies Inc.

https://trutrace.co/

TruTrace Technologies Inc. is a developer and deployer of cloud-based Software as a Service (SaaS) platforms designed to establish product integrity and supply chain traceability. The company's core technology integrates blockchain infrastructure with business operations to provide quality assurance, product lab testing validation, and anti-counterfeit measures for enterprise clients. Key offerings include TruTrace Enterprise™ SaaS, which serves industries such as food, cosmetics, and pharmaceuticals, and StrainSecure™ Cannabis SaaS, a specialized platform for managing quality, testing, and movement intelligence within the legal cannabis supply chain. TruTrace aims to deliver transparency and certainty by enabling clients to store, manage, share, and access verified product data from batches and lots to the end consumer.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of TruTrace Technologies Inc. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2022. It is a Form 52-109FV2 Certification of Interim Filings for a venture issuer. The content is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, without containing actual financial data or substantive financial analysis itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) they reference. The document length is short (3038 characters), and it does not contain the interim financial statements or detailed financial data, only the certification. Therefore, the correct classification is Regulatory Filings (RNS).
2022-12-23 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3046 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2022-12-23 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements For the three and six months ended October 31, 2022' and contains detailed unaudited financial statements including statements of financial position, operations, changes in shareholders' deficiency, and cash flows for interim periods. It explicitly states it is unaudited and prepared under National Instrument 51-102 for interim financial statements. The content includes substantive financial data and analysis for a period shorter than a full fiscal year (quarterly and half-year). This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or certification. Therefore, the correct classification is IR with high confidence.
2022-12-23 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion & Analysis' (MD&A) for the three and six months ended October 31, 2022 and 2021. It contains detailed discussion of financial condition, results of operations, forward-looking statements, non-IFRS financial measures, and extensive business and product descriptions. The document references quarterly interim financial statements and is dated December 23, 2022. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content matches the typical characteristics of an Interim / Quarterly Report, which includes substantive financial data and management's analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR).
2022-12-23 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement regarding updates to the agenda and voting procedures for a special meeting of shareholders scheduled for October 6, 2022. It discusses shareholder voting, proxy submissions, and meeting logistics, but does not contain financial statements, detailed financial performance, or management discussion. It is not a full report or financial filing but rather an update related to a shareholder meeting. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to shareholder voting matters and meeting updates.
2022-10-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short announcement (2299 characters) about the postponement of a special meeting of shareholders, including details about the new meeting date, proxy voting instructions, and meeting access via Zoom. It does not contain any financial data, detailed report content, or voting results. It is not a full report, transcript, or regulatory filing but rather a notice about a meeting schedule change. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2022-09-22 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.